Home
Companies
Deciphera Pharmaceuticals, Inc.

Deciphera Pharmaceuticals, Inc.

Company

Also known as: Deciphera Pharmaceuticals

Company Profile

Deciphera Pharmaceuticals is a biopharmaceutical company focused on discovering and developing medicines for cancer. Its portfolio centers on kinase inhibitor programs for serious oncologic diseases.

Website: https://www.deciphera.com
Headquarters: Waltham, Massachusetts, USA
Founded: 2003

Related News

Monash University Partners with Ono Pharmaceutical for Autoimmune Disease Therapies

Mar 23, 2026

Monash University and Ono Pharmaceutical have signed two licence agreements for the development of anti-GPCR antibodies targeting autoimmune and inflammatory diseases. The agreements result from Ono exercising options on research collaborations announced in 2023. The partnership combines Monash's research excellence with Ono's drug development capabilities to address unmet medical needs.

FDA Accepts Tirabrutinib NDA for Relapsed/Refractory PCNSL with December 2026 PDUFA Date

Feb 16, 2026

The FDA has accepted for filing the New Drug Application for tirabrutinib under the accelerated approval pathway for relapsed or refractory primary central nervous system lymphoma, setting a PDUFA action date of December 18, 2026.